Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
End stage kidney disease
What is your approach for minimizing volume intake for patients on dialysis who are receiving total parenteral nutrition (TPN)?
Related Questions
Would you avoid fistula placement in patients with ESKD secondary to scleroderma?
For patients on peritoneal dialysis with type 2 diabetes mellitus, do you have a preferred long- acting insulin and time of insulin administration?
How would you approach the timing of hemodialysis for an ESKD patient with no urgent indications who has NSTEMI with a troponin level of 10 ng/dl, has not had dialysis in 2 days, and is planned for left heart catheterization the next day?
Would you continue spironolactone in a patient who has recently progressed to ESKD on HD with oliguria and was diagnosed with primary hyperaldosteronism years ago?
What degree of prolactin elevation is typically seen in patients with end stage kidney disease on hemodialysis?
Do you have a preference between midodrine and droxidopa for patients with ESKD who experience intradialytic hypotension?
What is your approach for ESKD patients on peritoneal dialysis who request to do their own exchanges during a hospitalization?
Are there instances when you would prescribe a phosphate binder to an ESKD patient on hemodialysis who has a phosphorus level in the target range of less than 5.5 mg/dL?
Do you prefer peritoneal dialysis catheter and transfer set care to include soaking in antiseptic, applying alcohol wipes, or washing with soap and water?
Would you offer peritoneal dialysis to a patient with ESKD who also has dementia but lives with family who can assist with dialysis treatments?
